Rapid in vivo screening of experimental drugs for tuberculosis using gamma interferon gene-disrupted mice (Q34823666)

4 August 2017

title

Rapid in vivo screening of experimental drugs for tuberculosis using gamma interferon gene-disrupted mice (English)

1 reference

4 August 2017

0 references

0 references

Ian M Orme

1 reference

4 August 2017

Anne J M Lenaerts

1 reference

4 August 2017

Veronica Gruppo

1 reference

4 August 2017

Jason V Brooks

series ordinal

1 reference

4 August 2017

language of work or name

English

0 references

publication date

1 February 2003

1 reference

Antimicrobial Agents and Chemotherapy

4 August 2017

published in

1 reference

4 August 2017

1 reference

4 August 2017

1 reference

4 August 2017

page(s)

783-785

1 reference

Activities of several novel oxazolidinones against Mycobacterium tuberculosis in a murine model

4 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=151769

In vitro and in vivo activities of moxifloxacin and clinafloxacin against Mycobacterium tuberculosis.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=151769

The value of in vitro drug activity and pharmacokinetics in predicting the effectiveness of antimycobacterial therapy: a critical review

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=151769

Low-dose aerosol infection model for testing drugs for efficacy against Mycobacterium tuberculosis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=151769

Multiple defects of immune cell function in mice with disrupted interferon-gamma genes

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=151769

Disseminated tuberculosis in interferon gamma gene-disrupted mice

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=151769

Activity of levofloxacin in a murine model of tuberculosis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=151769

Activity of KRM-1648, a new benzoxazinorifamycin, against Mycobacterium tuberculosis in a murine model

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=151769

In vitro and in vivo activities of levofloxacin against Mycobacterium tuberculosis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=151769

An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=151769

[Experimental antitubercular activity of rifampicin, a derivative of rifamycin SV]

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=151769

The sterilizing value of rifampicin and pyrazinamide in experimental short-course chemotherapy

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=151769

Induction of granulomas in interferon-gamma gene-disrupted mice by avirulent but not by virulent strains of Mycobacterium tuberculosis.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=151769

Pharmacokinetics and elimination of moxifloxacin after oral and intravenous administration in man

26 October 2018

1 reference

12 December 2020

Pharmacokinetics of the 8-methoxyquinolone, moxifloxacin: a comparison in humans and other mammalian species

1 reference

12 December 2020

Long-term, two-stage chemotherpay of advanced experimental murine tuberculosis with intermittent regimes during the second stage

1 reference

12 December 2020

Suitability of isoniazid and ethambutol for intermittent administration in the treatment of tuberculosis

1 reference

12 December 2020

Suitability of rifampicin for intermittent administration in the treatment of tuberculosis

1 reference

12 December 2020

Preclinical safety evaluation of moxifloxacin, a novel fluoroquinolone

1 reference

12 December 2020

10.1128/AAC.47.2.783-785.2003

Identifiers

DOI

1 reference

release_hlmxae3hwvh73b422vusugdyfu

4 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/hlmxae3hwvh73b422vusugdyfu

24 November 2022

mapped directly with Wikidata item

PMC publication ID

151769

1 reference

4 August 2017

1 reference